Search - tctmd.com

Displaying 301 - 320 of 651

Sort: Relevancy | Date

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

Presenter: Saibal Kar

September 26, 2019

Presentation TCT 2019

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Presenter: Vivek Reddy

September 26, 2019

Presentation TCT 2019

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Presenter: Edip Gurol

September 26, 2019

Presentation TCT 2019

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

Presenter: William Gray

September 25, 2019

Presentation TCT 2019

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

Presenter: Kasper Korsholm

September 25, 2019

Presentation TCT 2019

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

Presenter: Jens Erik Nielsen-Kudsk

September 25, 2019

Presentation TCT 2019

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

Presenter: Xavier Freixa

September 25, 2019

Presentation TCT 2019

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Presenter: Swaiman Singh

September 25, 2019

Presentation TCT 2019

Case 10 (From Taiwan): A Challenging LAA Closure

Presenter: Ying-Hsiang Lee

September 25, 2019

Presentation TCT 2019

Learn the Technique (Case-Based): LAA Closure

Presenter: Alexey Protopopov

September 25, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

Presentation TVT 2019

Simultaneous LAA Closure With Structural Heart Procedures - WATCHMAN IN TAVR PATIENT

Presenter: Praveen Chandra

June 14, 2019

Presentation TVT 2019

LAA Closure in a Completely Awake Patient Using BossaNova and Intracardiac Echosonography Guidance

Presenter: Giselle Baquero

June 14, 2019

Presentation TVT 2019

Towards Simplifying the Workflow for Transcatheter Left Atrial Appendage Closure Using Preprocedural CT Planning and Intraprocedural Left Atrial Volume Intracardiac Echocardiography

Presenter: Vivian Ng

June 14, 2019

Advertisement

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX

LAA Closure vs. NOACs: Pros and Cons, PRAGUE 17, and Additional Trials

Patient Selection for LAA Closure: Risk Prediction Beyond CHA(2)DS(2)VASc and HAS-BLED

Second-Generation LAA Occlusion: Single-Size and Conforming to a Broad Range of Anatomies (Conformal Medical)

TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography

TCT 115: The novel Watchman FLX for left atrial appendage closure. Early European experience.

TCT 114: Comparative Data on Left Atrial Appendage Occlusion Efficacy and Clinical Outcomes by Age Group in the Amplatzer Amulet Observational Study

TCT 113: Adverse Events after Left Atrial Appendage Closure: Lessons Learned from the Manufacturer and User Facility Device Experience (MAUDE) database.

Case 10 (From Taiwan): A Challenging LAA Closure

Learn the Technique (Case-Based): LAA Closure

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Simultaneous LAA Closure With Structural Heart Procedures - WATCHMAN IN TAVR PATIENT

LAA Closure in a Completely Awake Patient Using BossaNova and Intracardiac Echosonography Guidance

Towards Simplifying the Workflow for Transcatheter Left Atrial Appendage Closure Using Preprocedural CT Planning and Intraprocedural Left Atrial Volume Intracardiac Echocardiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content